While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

Signing a plea agreement that bans hims from the grounds of the University of Virginia and makes him pay court costs, the ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.66 which represents a slight increase of $0.53 or 3.09% from the prior close of $17.13. The stock opened at $17.55 and ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

Global investment manager Oaktree is out with its third life sciences-dedicated special purpose acquisition company after ...

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported]( ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

Friday’s jobs report could bolster the view that the American economy is holding steady, but an oil price shock could ...

The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

The container ship Sky Light caused chaos while docking at a port in Constanța, Romania, on September 19. While attempting to ...

Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.